Bu, F., Zhang, S., Duan, Z., Ding, Y., Chen, T., Wang, R., Feng, Z., Shi, G., Zhou, J., & Chen, Y
Oral semaglutide versus empagliflozin, sitagliptin and liraglutide in the UK: long-term cost-effectiveness analyses based on the PIONEER clinical trial programme
Based on extensive research on these, and other brand name GLP-1s, the FDA recommends the medications for use in people with: A Body Mass Index (BMI) of 30 or higher A BMI of 27 or higher and at least one weight-related condition such as type 2 diabetes, high cholesterol, or elevated blood pressure
Martins, J
1,2 Gastroparesis is a chronic, relapsing condition characterized by delayed gastric emptying in the absence of other explainable causes (such as mechanical obstruction)
It is one of the best recovery tools for people who do not have space for a full sauna setup